Rodman & Renshaw Stock Ratings and Recommendations

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Rodman & Renshaw. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Rodman & Renshaw.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
8/10/2017Rodman & RenshawReiteratesValeant Pharmaceuticals (VRX)Neutral $17.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/10/2017Rodman & RenshawLowers TargetSynergy Pharmaceuticals (SGYP)Buy -> Buy$18.00 -> $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/10/2017Rodman & RenshawLowers TargetCorMedix (CRMD)Buy -> Buy$5.00 -> $3.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/9/2017Rodman & RenshawReiteratesGevo (GEVO)Buy $240.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/7/2017Rodman & RenshawInitiatesPOET Technologies (POETF)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
7/26/2017Rodman & RenshawInitiatesVeru (VERU)Buy -> Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/24/2017Rodman & RenshawReiteratesPlug Power (PLUG)Buy $4.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/22/2017Rodman & RenshawReiteratesCapricor Therapeutics (CAPR)Buy $2.15N/AView Rating Details  Share on Twitter  Share on StockTwits
7/14/2017Rodman & RenshawRaises TargetBeyondspring (BYSI)Buy -> Buy$43.00 -> $50.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/11/2017Rodman & RenshawInitiatesJaguar Health (JAGX)Buy -> Buy $2.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/11/2017Rodman & RenshawInitiatesFortress Biotech (FBIO)Buy -> Buy $11.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/2/2017Rodman & RenshawInitiatesAqua Metals (AQMS)Buy$25.00 -> $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/23/2017Rodman & RenshawReiterateseMagin (EMAN)Buy $4.00N/AView Rating Details  Share on Twitter  Share on StockTwits
6/22/2017Rodman & RenshawInitiatesAqua Metals (AQMS)Buy -> Buy $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/15/2017Rodman & RenshawInitiatesAmericas Silver (USA)Buy C$4.00N/AView Rating Details  Share on Twitter  Share on StockTwits
6/15/2017Rodman & RenshawInitiatesAmericas Silver (USAS)Buy -> Buy$4.00 -> $4.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/14/2017Rodman & RenshawReiteratesSynergy Pharmaceuticals (SGYP)Buy $18.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/12/2017Rodman & RenshawReiteratesVical (VICL)Buy -> Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/9/2017Rodman & RenshawReiteratesRexahn Pharmaceuticals (RNN)Buy $19.50N/AView Rating Details  Share on Twitter  Share on StockTwits
6/8/2017Rodman & RenshawInitiatesAptose Biosciences (APTO)Neutral -> NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
6/1/2017Rodman & RenshawReiteratesSophiris Bio (SPHS)Buy $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/30/2017Rodman & RenshawInitiatesEyepoint Pharmaceuticals (EYPT)Buy $8.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/30/2017Rodman & RenshawInitiatesPieris Pharmaceuticals (PIRS)Buy -> Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/23/2017Rodman & RenshawInitiatesCorvus Gold (KOR)Buy C$0.80N/AView Rating Details  Share on Twitter  Share on StockTwits
5/23/2017Rodman & RenshawReiteratesSynergy Pharmaceuticals (SGYP)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/23/2017Rodman & RenshawReiteratesProtalix Biotherapeutics (PLX)Buy $5.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/22/2017Rodman & RenshawReiteratesACADIA Pharmaceuticals (ACAD)Buy $60.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/22/2017Rodman & RenshawLowers TargetSorrento Therapeutics (SRNE)Buy -> Buy$30.00 -> $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/22/2017Rodman & RenshawLowers TargetPresbia (LENS)Buy -> Buy$14.00 -> $12.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/19/2017Rodman & RenshawReiteratesValeant Pharmaceuticals (VRX)Neutral $17.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/19/2017Rodman & RenshawRaises TargetPointer Telocation (PNTR)Buy -> Buy$10.00 -> $15.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/17/2017Rodman & RenshawReiteratesMagic Software Enterprises (MGIC)Buy -> Buy$9.00 -> $10.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/16/2017Rodman & RenshawLowers TargetTearLab (TEAR)Buy -> Buy$12.00 -> $4.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/16/2017Rodman & RenshawRaises TargetSTRATA Skin Sciences (SSKN)Buy -> Buy$1.50 -> $12.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/16/2017Rodman & RenshawRaises TargetHTG Molecular Diagnostics (HTGM)Buy -> Buy$4.50 -> $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/10/2017Rodman & RenshawInitiatesIovance Biotherapeutics (IOVA)Buy -> Buy $13.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/5/2017Rodman & RenshawLowers TargetCorMedix (CRMD)Buy$6.00 -> $5.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/1/2017Rodman & RenshawInitiatesAduro BioTech (ADRO)Buy -> Buy $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/28/2017Rodman & RenshawReiteratesAmerican Superconductor (AMSC)Buy -> Buy$10.00 -> $7.50HighView Rating Details  Share on Twitter  Share on StockTwits
4/27/2017Rodman & RenshawInitiatesAlimera Sciences (ALIM)Buy -> Buy $4.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/26/2017Rodman & RenshawInitiatesApricus Biosciences (APRI)Buy -> BuyLowView Rating Details  Share on Twitter  Share on StockTwits
4/25/2017Rodman & RenshawInitiatesResonant (RESN)Buy -> Buy $8.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/24/2017Rodman & RenshawRaises TargetRandgold Resources (GOLD)BuyC$4.25 -> C$4.50N/AView Rating Details  Share on Twitter  Share on StockTwits
4/24/2017Rodman & RenshawRaises TargetMOTIF BIO PLC/S (MTFB)Buy -> Buy$16.00 -> $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/17/2017Rodman & RenshawRaises TargetProtalix Biotherapeutics (PLX)Buy$4.00 -> $5.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/17/2017Rodman & RenshawReiteratesProtalix Biotherapeutics (PLX)Buy -> Buy$4.00 -> $5.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/10/2017Rodman & RenshawReiteratesWestern Copper and Gold (WRN)Buy C$2.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/10/2017Rodman & RenshawReiteratesCelsion (CLSN)Buy $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/7/2017Rodman & RenshawReiteratesWestern Copper and Gold (WRN)Buy $2.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/6/2017Rodman & RenshawReiteratesRexahn Pharmaceuticals (RNN)Buy -> Buy $2.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/6/2017Rodman & RenshawRaises TargetPlug Power (PLUG)Buy -> Buy$3.00 -> $4.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/6/2017Rodman & RenshawUpgradesSuperconductor Technologies (SCON)Neutral -> Buy $3.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/4/2017Rodman & RenshawReiteratesCELLECT BIOTECH/S (APOP)Buy$10.00 -> $1.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/4/2017Rodman & RenshawInitiatesBeyondspring (BYSI)Buy -> Buy $43.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/3/2017Rodman & RenshawReiteratesDRAGONWAVE Inc/SH NEW (DRWIQ)Buy $4.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/29/2017Rodman & RenshawReiteratesSynergy Pharmaceuticals (SGYP)Buy $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/29/2017Rodman & RenshawDowngradesExeter Resource (XRA)Buy -> Neutral $1.75N/AView Rating Details  Share on Twitter  Share on StockTwits
3/28/2017Rodman & RenshawInitiatesEnSync (ESNC)Buy $1.50N/AView Rating Details  Share on Twitter  Share on StockTwits
3/28/2017Rodman & RenshawReiteratesSophiris Bio (SPHS)Buy $6.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/23/2017Rodman & RenshawReiteratesCytokinetics (CYTK)Buy $25.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/22/2017Rodman & RenshawReiteratesImprimis Pharmaceuticals (IMMY)Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/21/2017Rodman & RenshawInitiatesParinga Resources (PNGZF)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
3/16/2017Rodman & RenshawReiteratesEvoke Pharma (EVOK)Buy -> Buy$6.00 -> $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/15/2017Rodman & RenshawInitiatesApplied Genetic Technologies (AGTC)Buy -> Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/13/2017Rodman & RenshawInitiatesSophiris Bio (SPHS)Buy -> Buy $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/13/2017Rodman & RenshawReiteratesMateon Therapeutics (MATN)Buy -> Buy $2.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/10/2017Rodman & RenshawReiteratesTearLab (TEAR)Buy -> Buy $12.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/9/2017Rodman & RenshawReiteratesMAG Silver (MAG)Buy -> Buy$20.00 -> $20.50LowView Rating Details  Share on Twitter  Share on StockTwits
3/8/2017Rodman & RenshawInitiatesCytokinetics (CYTK)Buy -> Buy $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/7/2017Rodman & RenshawInitiatesFibrocell Science (FCSC)Buy -> Buy $10.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/6/2017Rodman & RenshawLowers TargetValeant Pharmaceuticals (VRX)Neutral$23.00 -> $17.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/6/2017Rodman & RenshawReiteratesMagic Software Enterprises (MGIC)Buy -> Buy$8.00 -> $9.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/6/2017Rodman & RenshawInitiatesQuest Resource (QRHC)Buy -> Buy $5.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/6/2017Rodman & RenshawInitiatesExeter Resource (XRA)Buy $1.75N/AView Rating Details  Share on Twitter  Share on StockTwits
3/3/2017Rodman & RenshawReiteratesSynergy Pharmaceuticals (SGYP)Buy $18.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/27/2017Rodman & RenshawReiteratesValeant Pharmaceuticals (VRX)Neutral$23.00 -> $17.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/21/2017Rodman & RenshawReiteratesInspyr Therapeutics (NSPX)Buy $2.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/21/2017Rodman & RenshawReiteratesSTRATA Skin Sciences (SSKN)Buy -> Buy $1.50N/AView Rating Details  Share on Twitter  Share on StockTwits
2/13/2017Rodman & RenshawInitiatesCapricor Therapeutics (CAPR)Buy $14.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/13/2017Rodman & RenshawInitiatesBIOLINERX Ltd/S (BLRX)Buy $3.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/13/2017Rodman & RenshawInitiatesArch Therapeutics (ARTH)Buy $2.50N/AView Rating Details  Share on Twitter  Share on StockTwits
2/7/2017Rodman & RenshawReiteratesAbeona Therapeutics (ABEO)Buy$17.00 -> $20.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/6/2017Rodman & RenshawInitiatesNovaBay Pharmaceuticals (NBY)Buy $6.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/6/2017Rodman & RenshawInitiatesAdvanced Emissions Solutions (ADES)Buy $18.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/31/2017Rodman & RenshawDowngradesValeant Pharmaceuticals (VRX)Buy -> NeutralN/AView Rating Details  Share on Twitter  Share on StockTwits
1/25/2017Rodman & RenshawDowngradesGenVec (GNVC)Buy -> Neutral$15.00 -> $7.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/24/2017Rodman & RenshawRaises TargetAvino Silver & Gold Mines (ASM)BuyC$3.50 -> C$4.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/20/2017Rodman & RenshawRaises TargetSynergy Pharmaceuticals (SGYP)Buy$17.00 -> $18.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/19/2017Rodman & RenshawInitiatesCheck Cap (CHEK)Buy $72.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/11/2017Rodman & RenshawReiteratesAmyris (AMRS)Buy $60.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/9/2017Rodman & RenshawInitiatesMotif Bio (MTFB)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
1/9/2017Rodman & RenshawInitiatesMOTIF BIO PLC/S (MTFB)Buy $16.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/7/2017Rodman & RenshawReiteratesMagneGas (MNGA)Buy $30.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/5/2017Rodman & RenshawUpgradesEvoke Pharma (EVOK)Neutral -> Buy$2.50 -> $6.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/4/2017Rodman & RenshawInitiatesRitter Pharmaceuticals (RTTR)Buy $70.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/3/2017Rodman & RenshawInitiatesChromadex (CDXC)Buy $6.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/31/2016Rodman & RenshawRaises TargetEvoke Pharma (EVOK)Neutral$2.00 -> $2.50N/AView Rating Details  Share on Twitter  Share on StockTwits
12/31/2016Rodman & RenshawRaises TargetSynergy Pharmaceuticals (SGYP)Buy$16.00 -> $17.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/23/2016Rodman & RenshawRaises TargetSynergy Pharmaceuticals (SGYP)Buy$16.00 -> $17.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/23/2016Rodman & RenshawRaises TargetEvoke Pharma (EVOK)Neutral$2.00 -> $2.50N/AView Rating Details  Share on Twitter  Share on StockTwits
12/13/2016Rodman & RenshawReiteratesSynergy Pharmaceuticals (SGYP)Buy$15.00 -> $16.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/12/2016Rodman & RenshawDowngradesCerecor (CERC)Buy -> NeutralN/AView Rating Details  Share on Twitter  Share on StockTwits
12/6/2016Rodman & RenshawInitiatesPlug Power (PLUG)Buy $3.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/2/2016Rodman & RenshawRaises TargetGenVec (GNVC)Buy$2.30 -> $15.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/1/2016Rodman & RenshawReiteratesEyegate Pharmaceuticals (EYEG)Buy $10.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/30/2016Rodman & RenshawReiteratesSynergy Pharmaceuticals (SGYP)Buy $15.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/28/2016Rodman & RenshawRaises TargetGoldMining (GOLD)BuyC$4.00 -> C$4.25N/AView Rating Details  Share on Twitter  Share on StockTwits
11/28/2016Rodman & RenshawInitiatesImprimis Pharmaceuticals (IMMY)Buy $5.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/11/2016Rodman & RenshawReiteratesSynergy Pharmaceuticals (SGYP)Buy $15.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/10/2016Rodman & RenshawInitiatesCELLECT BIOTECH/S (APOP)Buy $10.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/10/2016Rodman & RenshawDowngradesValeant Pharmaceuticals (VRX)Buy -> Neutral$81.00 -> $23.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2016Rodman & RenshawLowers TargetHydrogenics (HYGS)Buy$11.00 -> $10.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/21/2016Rodman & RenshawReiteratesNeurometrix (NURO)Buy $36.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/21/2016Rodman & RenshawInitiatesAbraxas Petroleum (AXAS)Buy $3.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/15/2016Rodman & RenshawReiteratesTearLab (TEAR)Buy $20.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/7/2016Rodman & RenshawLowers TargetGogold Resources (GGD)BuyC$3.50 -> C$3.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/6/2016Rodman & RenshawInitiatesCytoDyn (CYDY)Buy $1.60N/AView Rating Details  Share on Twitter  Share on StockTwits
10/5/2016Rodman & RenshawInitiatesResolute Energy (REN)Buy $32.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/4/2016Rodman & RenshawInitiatesTecogen (TGEN)Buy $6.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/27/2016Rodman & RenshawReiteratesDURECT (DRRX)Buy$4.00 -> $3.50N/AView Rating Details  Share on Twitter  Share on StockTwits
9/26/2016Rodman & RenshawInitiatesAytu Bioscience (AYTU)Buy $9.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/26/2016Rodman & RenshawInitiatesCancer Genetics (CGIX)Buy $6.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/23/2016Rodman & RenshawReiteratesClean Energy Fuels (CLNE)Buy$5.00 -> $6.30N/AView Rating Details  Share on Twitter  Share on StockTwits
9/22/2016Rodman & RenshawRaises TargetEnergy Fuels (UUUU)Buy$5.00 -> $6.30N/AView Rating Details  Share on Twitter  Share on StockTwits
9/22/2016Rodman & RenshawLowers TargetEnergy Fuels (UUUU)Buy$6.30 -> $5.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/12/2016Rodman & RenshawInitiatesOASMIA PHARMACE/ADR (OASM)Buy$6.00 -> $6.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/8/2016Rodman & RenshawReiteratesSynergy Pharmaceuticals (SGYP)Buy $15.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/7/2016Rodman & RenshawLowers TargetVolitionRX (VNRX)Buy$12.00 -> $10.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/7/2016Rodman & RenshawReiteratesVolitionRX (VNRX)Buy$12.00 -> $10.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/7/2016Rodman & RenshawInitiatesMidwest Energy Emissions (MEEC)Buy $2.50N/AView Rating Details  Share on Twitter  Share on StockTwits
9/6/2016Rodman & RenshawInitiatesDRAGONWAVE Inc/SH NEW (DRWIQ)Buy $4.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/6/2016Rodman & RenshawInitiatesHecla Mining (HL)Buy $9.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/4/2016Rodman & RenshawSet Price TargetNeurometrix (NURO)Buy $36.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/31/2016Rodman & RenshawSet Price TargetBiocept (BIOC)Buy $2.50N/AView Rating Details  Share on Twitter  Share on StockTwits
8/29/2016Rodman & RenshawInitiatesCAN-FITE BIOPHA/S (CANF)Buy $6.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/29/2016Rodman & RenshawInitiatesRing Energy (REI)Buy $15.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/22/2016Rodman & RenshawReiteratesDarioHealth (DRIO)Buy $12.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/22/2016Rodman & RenshawInitiatesMateon Therapeutics (MATN)Buy $2.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/22/2016Rodman & RenshawInitiatesHTG Molecular Diagnostics (HTGM)Buy $5.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/21/2016Rodman & RenshawSet Price TargetMiragen Therapeutics (MGEN)Buy $4.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/21/2016Rodman & RenshawReiteratesOramed Pharmaceuticals (ORMP)Buy $25.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/21/2016Rodman & RenshawReiteratesAbeona Therapeutics (ABEO)Buy $17.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/18/2016Rodman & RenshawReiteratesSierra Metals (SMT)Buy C$3.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/15/2016Rodman & RenshawRaises TargetEnergy Focus (EFOI)Buy$8.00 -> $16.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/13/2016Rodman & RenshawReiteratesSynergy Pharmaceuticals (SGYP)Buy $15.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/10/2016Rodman & RenshawSet Price TargetOpGen (OPGN)Buy $82.50N/AView Rating Details  Share on Twitter  Share on StockTwits
8/11/2016Rodman & RenshawSet Price TargetBio-Path (BPTH)Buy $50.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/10/2016Rodman & RenshawReiteratesBioSpecifics Technologies (BSTC)Buy $60.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/9/2016Rodman & RenshawLowers TargetValeant Pharmaceuticals (VRX)Buy$90.00 -> $81.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/5/2016Rodman & RenshawReiteratesTearLab (TEAR)Buy $20.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/5/2016Rodman & RenshawReiteratesAbeona Therapeutics (ABEO)Buy $17.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/3/2016Rodman & RenshawReiteratesDURECT (DRRX)Buy $4.00N/AView Rating Details  Share on Twitter  Share on StockTwits
7/31/2016Rodman & RenshawReiteratesEkso Bionics (EKSO)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
7/28/2016Rodman & RenshawReiteratesValeant Pharmaceuticals (VRX)Buy $90.00N/AView Rating Details  Share on Twitter  Share on StockTwits
7/26/2016Rodman & RenshawReiteratesSecond Sight Medical Products (EYES)Buy $16.00N/AView Rating Details  Share on Twitter  Share on StockTwits
7/22/2016Rodman & RenshawReiteratesNeurometrix (NURO)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
7/21/2016Rodman & RenshawSet Price TargetPresbia (LENS)Buy $14.00N/AView Rating Details  Share on Twitter  Share on StockTwits
7/21/2016Rodman & RenshawInitiatesOncoSec Medical (ONCS)Buy $6.00N/AView Rating Details  Share on Twitter  Share on StockTwits
7/18/2016Rodman & RenshawReiteratesDelMar Pharmaceuticals (DMPI)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
7/18/2016Rodman & RenshawInitiatesFord Motor (F)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
7/18/2016Rodman & RenshawDowngradesEvoke Pharma (EVOK)Buy -> Neutral $2.00N/AView Rating Details  Share on Twitter  Share on StockTwits
7/18/2016Rodman & RenshawInitiatesOrion Energy Systems (OESX)Buy $2.50N/AView Rating Details  Share on Twitter  Share on StockTwits
7/17/2016Rodman & RenshawReiteratesSorrento Therapeutics (SRNE)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
7/17/2016Rodman & RenshawReiteratesValeant Pharmaceuticals (VRX)Buy $90.00N/AView Rating Details  Share on Twitter  Share on StockTwits
7/12/2016Rodman & RenshawReiteratesSynergy Pharmaceuticals (SGYP)Buy $15.00N/AView Rating Details  Share on Twitter  Share on StockTwits
7/12/2016Rodman & RenshawInitiatesTearLab (TEAR)Buy $20.00N/AView Rating Details  Share on Twitter  Share on StockTwits
7/11/2016Rodman & RenshawReiteratesBioblast Pharma (ORPN)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
7/11/2016Rodman & RenshawReiteratesKITOV PHARMA LT/S (KTOV)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
7/11/2016Rodman & RenshawReiteratesBio-Path (BPTH)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
7/11/2016Rodman & RenshawReiteratesSorrento Therapeutics (SRNE)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
7/11/2016Rodman & RenshawReiteratesProtalix Biotherapeutics (PLX)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
7/11/2016Rodman & RenshawReiteratesEvoke Pharma (EVOK)Buy $27.00N/AView Rating Details  Share on Twitter  Share on StockTwits
7/6/2016Rodman & RenshawReiteratesValeant Pharmaceuticals (VRX)Buy $90.00N/AView Rating Details  Share on Twitter  Share on StockTwits
7/6/2016Rodman & RenshawReiteratesDURECT (DRRX)Buy $4.00N/AView Rating Details  Share on Twitter  Share on StockTwits
6/30/2016Rodman & RenshawInitiatesCatalyst Biosciences (CBIO)Buy $52.50N/AView Rating Details  Share on Twitter  Share on StockTwits
6/29/2016Rodman & RenshawInitiatesOpGen (OPGN)Buy $62.50N/AView Rating Details  Share on Twitter  Share on StockTwits
6/28/2016Rodman & RenshawInitiatesNeurometrix (NURO)Buy $36.00N/AView Rating Details  Share on Twitter  Share on StockTwits
6/21/2016Rodman & RenshawReiteratesInovio Pharmaceuticals (INO)Buy $17.00N/AView Rating Details  Share on Twitter  Share on StockTwits
6/20/2016Rodman & RenshawReiteratesGenVec (GNVC)Buy $23.00N/AView Rating Details  Share on Twitter  Share on StockTwits
6/20/2016Rodman & RenshawInitiatesWestport Fuel Systems (WPRT)Buy $5.00N/AView Rating Details  Share on Twitter  Share on StockTwits
6/16/2016Rodman & RenshawReiteratesVolitionRX (VNRX)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
6/13/2016Rodman & RenshawReiteratesEyegate Pharmaceuticals (EYEG)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
6/13/2016Rodman & RenshawReiteratesBioSpecifics Technologies (BSTC)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
6/8/2016Rodman & RenshawReiteratesSorrento Therapeutics (SRNE)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
6/2/2016Rodman & RenshawReiteratesBioSpecifics Technologies (BSTC)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
5/24/2016Rodman & RenshawReiteratesDelMar Pharmaceuticals (DMPI)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
5/24/2016Rodman & RenshawReiteratesDarioHealth (DRIO)Buy $12.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/24/2016Rodman & RenshawReiteratesBiocept (BIOC)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
5/24/2016Rodman & RenshawReiteratesNanosphere (NSPH)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
5/24/2016Rodman & RenshawInitiatesPacific Ethanol (PEIX)Buy $11.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/23/2016Rodman & RenshawReiteratesPresbia (LENS)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
5/23/2016Rodman & RenshawReiteratesJust Energy Group (JE)Buy $10.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/23/2016Rodman & RenshawReiteratesSynergy Pharmaceuticals (SGYP)Buy $15.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/18/2016Rodman & RenshawReiteratesAbeona Therapeutics (ABEO)Buy $17.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/17/2016Rodman & RenshawReiteratesAsterias Biotherapeutics (AST)Buy $10.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/16/2016Rodman & RenshawReiteratesVolitionRX (VNRX)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
5/17/2016Rodman & RenshawDowngradesNanosphere (NSPH)Buy -> Neutral$2.00 -> $1.35N/AView Rating Details  Share on Twitter  Share on StockTwits
5/14/2016Rodman & RenshawReiteratesKITOV PHARMA LT/S (KTOV)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
5/13/2016Rodman & RenshawReiteratesDURECT (DRRX)Buy $4.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/13/2016Rodman & RenshawReiteratesOramed Pharmaceuticals (ORMP)Buy $25.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/12/2016Rodman & RenshawReiteratesEyegate Pharmaceuticals (EYEG)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
5/12/2016Rodman & RenshawReiteratesEvoke Pharma (EVOK)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
5/10/2016Rodman & RenshawReiteratesRegeneRx Biopharmaceuticals (RGRX)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
5/10/2016Rodman & RenshawReiteratesMicrobot Medical (MBOT)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
5/10/2016Rodman & RenshawInitiatesPresbia (LENS)Buy $14.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/9/2016Rodman & RenshawLowers TargetSynergy Pharmaceuticals (SGYP)Buy$16.00 -> $15.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/9/2016Rodman & RenshawInitiatesDarioHealth (DRIO)Buy $12.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/3/2016Rodman & RenshawLowers TargetValeant Pharmaceuticals (VRX)Buy$105.00 -> $102.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/2/2016Rodman & RenshawInitiatesKlondex Mines (KLDX)Buy $4.75N/AView Rating Details  Share on Twitter  Share on StockTwits
4/30/2016Rodman & RenshawUpgradesCaladrius Biosciences (CLBS)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
4/29/2016Rodman & RenshawReiteratesRegeneRx Biopharmaceuticals (RGRX)Buy $2.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/26/2016Rodman & RenshawReiteratesValeant Pharmaceuticals (VRX)Buy $105.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/25/2016Rodman & RenshawInitiatesAsterias Biotherapeutics (AST)Buy $12.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/25/2016Rodman & RenshawInitiatesDURECT (DRRX)Buy $4.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/21/2016Rodman & RenshawReiteratesVolitionRX (VNRX)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
4/21/2016Rodman & RenshawReiteratesSynergy Pharmaceuticals (SGYP)Buy $16.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/20/2016Rodman & RenshawReiteratesAbeona Therapeutics (ABEO)Buy $17.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/20/2016Rodman & RenshawInitiatesMicrobot Medical (MBOT)Buy $18.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/18/2016Rodman & RenshawInitiatesBio-Path (BPTH)Buy $50.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/15/2016Rodman & RenshawReiteratesNephroGenex (NRXGQ)NeutralN/AView Rating Details  Share on Twitter  Share on StockTwits
4/15/2016Rodman & RenshawRaises TargetFirst Majestic Silver (AG)Buy$6.00 -> $8.75N/AView Rating Details  Share on Twitter  Share on StockTwits
4/15/2016Rodman & RenshawInitiatesSemler Scientific (SMLR)Buy $8.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/14/2016Rodman & RenshawRaises TargetGreat Panther Silver (GPL)Buy$1.10 -> $1.50N/AView Rating Details  Share on Twitter  Share on StockTwits
4/13/2016Rodman & RenshawInitiatesCerecor (CERCU)Buy $15.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/13/2016Rodman & RenshawInitiatesMagneGas (MNGA)Buy $30.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/13/2016Rodman & RenshawInitiatesCerecor (CERC)Buy $15.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/12/2016Rodman & RenshawRaises TargetEndeavour Silver (EXK)Buy$2.50 -> $3.40N/AView Rating Details  Share on Twitter  Share on StockTwits
4/11/2016Rodman & RenshawLowers TargetValeant Pharmaceuticals (VRX)Buy$118.00 -> $105.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/9/2016Rodman & RenshawReiteratesInovio Pharmaceuticals (INO)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
4/9/2016Rodman & RenshawReiteratesVolitionRX (VNRX)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
4/9/2016Rodman & RenshawDowngradesNephroGenex (NRXGQ)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
4/5/2016Rodman & RenshawLowers TargetSorrento Therapeutics (SRNE)Buy$40.00 -> $30.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/5/2016Rodman & RenshawReiteratesEkso Bionics (EKSO)Buy $21.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/4/2016Rodman & RenshawInitiatesDelMar Pharmaceuticals (DMPI)Buy $3.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/4/2016Rodman & RenshawInitiatesProtalix Biotherapeutics (PLX)Buy $3.50N/AView Rating Details  Share on Twitter  Share on StockTwits
4/3/2016Rodman & RenshawReiteratesValeant Pharmaceuticals (VRX)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
4/1/2016Rodman & RenshawReiteratesAmerican Superconductor (AMSC)NeutralN/AView Rating Details  Share on Twitter  Share on StockTwits
3/31/2016Rodman & RenshawReiteratesBiocept (BIOC)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
3/31/2016Rodman & RenshawInitiatesDS Healthcare Group (DSKX)Buy $1.50N/AView Rating Details  Share on Twitter  Share on StockTwits
3/31/2016Rodman & RenshawReiteratesEyegate Pharmaceuticals (EYEG)Buy $10.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/30/2016Rodman & RenshawInitiatesSuperconductor Technologies (SCON)NeutralN/AView Rating Details  Share on Twitter  Share on StockTwits
3/28/2016Rodman & RenshawReiteratesValeant Pharmaceuticals (VRX)Buy $118.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/29/2016Rodman & RenshawLowers TargetInspireMD (NSPR)Buy$140.00 -> $105.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/29/2016Rodman & RenshawReiteratesInspireMD (NSPR)Buy$140.00 -> $105.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/23/2016Rodman & RenshawReiteratesBiocept (BIOC)Buy $4.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/22/2016Rodman & RenshawReiteratesValeant Pharmaceuticals (VRX)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
3/22/2016Rodman & RenshawLowers TargetBioblast Pharma (ORPN)Buy$125.00 -> $115.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/21/2016Rodman & RenshawReiteratesSorrento Therapeutics (SRNE)Buy $40.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/21/2016Rodman & RenshawLowers TargetSynergy Pharmaceuticals (SGYP)Buy$17.00 -> $16.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/21/2016Rodman & RenshawInitiatesNANO DIMENSION/S (NNDM)Buy $14.00N/AView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Thursday at 07:21 AM ET.

MarketBeat Community Rating for Rodman & Renshaw

Community Ranking:  0.0 out of 5 (star star star)
Outperform Votes:  0 (Vote Outperform)
Underperform Votes:  10,273 (Vote Underperform)
Total Votes:  10,273
MarketBeat's community ratings are surveys of what our community members think about Rodman & Renshaw and other research firms. Vote "Outperform" if you believe Rodman & Renshaw's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Rodman & Renshaw's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.